[ad_1]
Chief Earnings Strategist Marc Lichtenfeld is a large fan of firms with robust and rising money circulate. Anybody who’s spent only a few minutes round him is aware of that.
Should you suppose I’m exaggerating… suppose once more.
Marc not too long ago advised me a narrative a couple of salesman coming to his home to promote a sure firm’s merchandise. When Marc heard the identify of the corporate, he replied, “Oh, I’ve heard of it. Nice firm. Generates a ton of money circulate.”
(The salesperson, after all, wasn’t positive how you can reply.)
Final week, Marc sat down for an interview with our associates at MarketBeat to debate why traders ought to pay far more consideration to money circulate than earnings.
He additionally gave away the names and tickers of two potential diamonds within the tough to purchase now and two “ticking time bomb” shares to keep away from:
- A longtime drugmaker whose free money circulate is projected to triple this yr
- An under-the-radar strategy to get publicity to the AI house
- A family identify (actually) that has been bleeding billions of {dollars} for the previous decade
- An organization that he says is “full rubbish” and whose earnings are “a joke”!
Click on the picture above to observe the complete interview and get the main points on all 4 shares!
[ad_2]
